Equities

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)6.62
  • Today's Change-2.66 / -28.66%
  • Shares traded1.11m
  • 1 Year change-36.47%
  • Beta1.0038
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

SmartText is unavailable
Gross margin90.24%
Net profit margin15.15%
Operating margin13.98%
Return on assets3.76%
Return on equity4.49%
Return on investment4.43%
More ▼

Cash flow in CNYView more

SmartText is unavailable
Cash flow per share--
Price/Cash flow per share--
Book value per share2.27
Tangible book value per share2.20
More ▼

Balance sheet in CNYView more

SmartText is unavailable
Current ratio6.23
Quick ratio6.06
Total debt/total equity0.0048
Total debt/total capital0.0048
More ▼

Growth rates in CNY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -21.51%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)88.68%
EPS growth(5 years)-2.87
EPS (TTM) vs
TTM 1 year ago
-46.68
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.